Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972684/
http://dx.doi.org/10.1007/s40278-022-12362-8
_version_ 1784679898550370304
collection PubMed
description
format Online
Article
Text
id pubmed-8972684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89726842022-04-01 Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine Reactions Weekly Clinical Study Springer International Publishing 2022-04-02 2022 /pmc/articles/PMC8972684/ http://dx.doi.org/10.1007/s40278-022-12362-8 Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title_full Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title_fullStr Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title_full_unstemmed Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title_short Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
title_sort myocarditis after third dose of pfizer-biontech covid-19 vaccine
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972684/
http://dx.doi.org/10.1007/s40278-022-12362-8

Ejemplares similares